Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study

Autor: Bashorun, Adedapo O, Kotei, Larry, Jawla, Ousubie, Jallow, Abdoulie F, Saidy, Aisha J, Kinteh, Ma-Ansu, Kujabi, Arafang, Jobarteh, Tijan, Kanu, Francis John, Donkor, Simon A, Ezeani, Esu, Fofana, Sidat, Njie, Mbye, Ceesay, Lamin, Jafri, Basit, Williams, Amanda, Jeffries, David, Kotanmi, Brezesky, Mainou, Bernardo A, Ooko, Michael, Clarke, Ed *
Zdroj: In The Lancet Infectious Diseases April 2024 24(4):417-426
Databáze: ScienceDirect